What does this research mean for the field?

Left ventricular hypertrophy in pregnant women with chronic hypertension is independently associated with higher risks of adverse maternal and fetal outcomes. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess whether left ventricular hypertrophy (LVH) predicts adverse maternal and fetal outcomes in pregnant women with chronic hypertension.

August 25, 2026Hypertension in PregnancyOpen Access

LVH in hypertensive pregnancies is linked to ~116% higher risk of adverse maternal and fetal outcomes.

Q: What is the clinical evidence from this study?

Study design: Cohort. Population: Chronic hypertension in pregnancy (n=500). Intervention: Left ventricular hypertrophy vs. Absence of left ventricular hypertrophy. Primary outcome: Adverse maternal outcomes (OR 2.16, 95% CI 1.13-4.13).

View Full Paper

Ask AI

Bookmark

Why the study?

The impact of chronic hypertension combined with left ventricular hypertrophy on adverse maternal and fetal pregnancy outcomes remains unclear.

Does left ventricular hypertrophy predict adverse maternal and fetal outcomes in pregnant women with chronic hypertension?

Population

500 pregnant women with CHTN from four tertiary hospitals in China

Comparison

Presence of LVH vs absence or across LV geometry patterns

Design

Multicenter retrospective cohort study

Key result

Left ventricular hypertrophy in pregnant women with chronic hypertension was associated with higher risks of adverse maternal (OR 2.16; 95% CI 1.13-4.13) and fetal outcomes.

Authors

BZBei ZhangShandong Provincial Hospital GPGuilong PanShandong Provincial Hospital WWWei WangShandong Provincial Hospital

Discussion

Member takes

Overview

May warrant closer monitoring in chronic hypertensive pregnancies with LVH; leaves open whether intervention alters outcomes.

Key Points

To assess whether left ventricular hypertrophy (LVH) predicts adverse maternal and fetal outcomes in pregnant women with chronic hypertension.
Multicenter retrospective cohort study of N=500 pregnant women with chronic hypertension across four tertiary hospitals in China.
Assessed cardiac geometry classifications and applied logistic regression and four machine learning algorithms with SHAP interpretation to evaluate risk factors.
Adverse maternal outcomes occurred in 25.2% (126/500) and adverse fetal outcomes in 71.8% (359/500) of pregnancies.
LVH was an independent predictor for both adverse maternal outcomes (OR 2.16, 95% CI 1.13–4.13) and adverse fetal outcomes (OR 2.42, 95% CI 1.31–4.45).
Machine learning models predicted maternal outcomes with AUCs of 0.70–0.87 and fetal outcomes with AUCs of 0.80–0.88, consistently highlighting LVH as a key contributor.

Study Design

Type

Cohort (n=500)

Multicenter

Yes

Structured PICO

Does left ventricular hypertrophy predict adverse maternal and fetal outcomes in pregnant women with chronic hypertension?

Population

500 pregnant women with chronic hypertension evaluated for the impact of left ventricular hypertrophy on maternal and fetal outcomes.

Exposure

Left ventricular hypertrophy (LVH)

Comparator

Normal left ventricular geometry

Outcome

Adverse maternal and fetal pregnancy outcomescomposite

Main Result

Odds Ratio: 2.16 (95% CI 1.13–4.13)

Early-pregnancy left ventricular hypertrophy is a significant independent predictor of adverse maternal and fetal outcomes in women with chronic hypertension.

Limitations

Requires prospective external validation before clinical implementation
requires prospective external validation before clinical implementation

Cite This Study

Zhang et al. (2026) conducted a cohort in Chronic hypertension in pregnancy (n=500). Left ventricular hypertrophy vs. Absence of left ventricular hypertrophy was evaluated on Adverse maternal outcomes (OR 2.16, 95% CI 1.13-4.13). Left ventricular hypertrophy in pregnant women with chronic hypertension was associated with higher risks of adverse maternal (OR 2.16; 95% CI 1.13-4.13) and fetal outcomes.

synapsesocial.com/papers/6a8d49f7e8bd2413309bbde2 https://doi.org/10.1080/10641955.2026.2719498

View Full Paper

Ask AI

Bookmark

August 25, 2026Hypertension in PregnancyOpen Access

LVH in hypertensive pregnancies is linked to ~116% higher risk of adverse maternal and fetal outcomes.

View Full Paper

Ask AI

Bookmark

Why the study?

The impact of chronic hypertension combined with left ventricular hypertrophy on adverse maternal and fetal pregnancy outcomes remains unclear.

Does left ventricular hypertrophy predict adverse maternal and fetal outcomes in pregnant women with chronic hypertension?

Population

500 pregnant women with CHTN from four tertiary hospitals in China

Comparison

Presence of LVH vs absence or across LV geometry patterns

Design

Multicenter retrospective cohort study

Key result

Left ventricular hypertrophy in pregnant women with chronic hypertension was associated with higher risks of adverse maternal (OR 2.16; 95% CI 1.13-4.13) and fetal outcomes.

Authors

BZBei ZhangShandong Provincial Hospital GPGuilong PanShandong Provincial Hospital WWWei WangShandong Provincial Hospital

Discussion

Member takes

Overview

May warrant closer monitoring in chronic hypertensive pregnancies with LVH; leaves open whether intervention alters outcomes.

Key Points

To assess whether left ventricular hypertrophy (LVH) predicts adverse maternal and fetal outcomes in pregnant women with chronic hypertension.
Multicenter retrospective cohort study of N=500 pregnant women with chronic hypertension across four tertiary hospitals in China.
Assessed cardiac geometry classifications and applied logistic regression and four machine learning algorithms with SHAP interpretation to evaluate risk factors.
Adverse maternal outcomes occurred in 25.2% (126/500) and adverse fetal outcomes in 71.8% (359/500) of pregnancies.
LVH was an independent predictor for both adverse maternal outcomes (OR 2.16, 95% CI 1.13–4.13) and adverse fetal outcomes (OR 2.42, 95% CI 1.31–4.45).
Machine learning models predicted maternal outcomes with AUCs of 0.70–0.87 and fetal outcomes with AUCs of 0.80–0.88, consistently highlighting LVH as a key contributor.

Study Design

Type

Cohort (n=500)

Multicenter

Yes

Structured PICO

Does left ventricular hypertrophy predict adverse maternal and fetal outcomes in pregnant women with chronic hypertension?

Population

500 pregnant women with chronic hypertension evaluated for the impact of left ventricular hypertrophy on maternal and fetal outcomes.

Exposure

Left ventricular hypertrophy (LVH)

Comparator

Normal left ventricular geometry

Outcome

Adverse maternal and fetal pregnancy outcomescomposite

Main Result

Odds Ratio: 2.16 (95% CI 1.13–4.13)

Early-pregnancy left ventricular hypertrophy is a significant independent predictor of adverse maternal and fetal outcomes in women with chronic hypertension.

Limitations

Requires prospective external validation before clinical implementation
requires prospective external validation before clinical implementation

Cite This Study

synapsesocial.com/papers/6a8d49f7e8bd2413309bbde2 https://doi.org/10.1080/10641955.2026.2719498

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark